CompletedNot applicableNCT02713464

Does Maternal Instruction Prevent Kernicterus in Nigeria?

Studying Bilirubin encephalopathy

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Bilimetrix s.r.l.
Principal Investigator: Stephen Oguche, MBBS, NP
Jos University Teaching Hospital
Intervention: maternal education(behavioral)
Enrollment: 1765 enrolled
Eligibility: All sexes
Timeline: 2014 – 2015

Collaborators

Jos University Teaching Hospital · Bayern University Teaching Hospital · Ahmadu Bello University Teaching Hospital · Massey Street Children's Hospital · Federal Medical Center Asaba · University of Minnesota

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02713464 on ClinicalTrials.gov

Other trials for Bilirubin encephalopathy

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT04584983
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
The University of Texas Health Science Center, Houston

See all trials for Bilirubin encephalopathy →

← Back to all trials